Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) FCF Margin (2024 - 2025)

Historic FCF Margin for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to 400.93%.

  • Kura Oncology's FCF Margin fell 109446200.0% to 400.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 167.08%, marking a year-over-year change of. This contributed to the annual value of 248.4% for FY2024, which is 78208100.0% down from last year.
  • As of Q3 2025, Kura Oncology's FCF Margin stood at 400.93%, which was down 109446200.0% from 197.77% recorded in Q2 2025.
  • Kura Oncology's 5-year FCF Margin high stood at 12293.47% for Q1 2024, and its period low was 66689.58% during Q4 2024.